Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2010
12/16/2010US20100316604 Interferon lambda fusion polypeptides
12/16/2010US20100316603 Combination Immunogene Therapy
12/16/2010US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions
12/16/2010US20100316600 Methods of treating cancer using il-21
12/16/2010US20100316599 Methods of treating cancer using il-21
12/16/2010US20100316598 Methods of treating cancer using il-21
12/16/2010US20100316597 Methods of treating cancer using il-21
12/16/2010US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy
12/16/2010US20100316563 Method For The Preparation Of New Oligoclonal Antibodies
12/16/2010DE112008001452T5 Pflanzen mit erhöhter Toleranz und/oder Resistenz gegen Umweltstress und erhöhter Biomasseproduktion Plants with increased tolerance and / or resistance to environmental stress and increased biomass production
12/16/2010DE102009024603A1 Preparing bioactive, dental hard tissue sealed toothpaste comprises enzyme-catalyzed formation of nanoparticles comprising amorphous silicon dioxide using a polypeptide comprising animal, bacterial, plant or fungal silicatein domains
12/16/2010CA2768246A1 Serine rich peptides having antioxidative stress properties
12/16/2010CA2765099A1 Immunological targeting of pathological tau proteins
12/16/2010CA2764890A1 Methods for increasing thermogenic adipocytes
12/16/2010CA2764828A1 Hydrophobins for dispersing active agents
12/16/2010CA2764777A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/16/2010CA2764760A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy
12/16/2010CA2764562A1 Vaccine therapy for choroidal neovascularization
12/16/2010CA2764559A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stresstolerance
12/16/2010CA2764105A1 Growth hormone polypeptides and methods of making and using same
12/16/2010CA2761121A1 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
12/15/2010EP2261710A1 Optical coupling device with optical waveguide coupled to optical device
12/15/2010EP2261709A1 Optical coupling device with optical waveguide coupled to optical device
12/15/2010EP2261671A2 Diagnostic assay for human Matrix-Gla-Protein and its use as a biomarker
12/15/2010EP2261667A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and their therapy of ovarian cancer
12/15/2010EP2261380A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261378A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261377A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261376A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins
12/15/2010EP2261375A2 Method of Preventing Virus:Cell Fusion By Inhibiting the Function of the Fusion Initiation Region in RNA Viruses Having Class I Membrane Fusogenic Envelope Proteins
12/15/2010EP2261374A2 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
12/15/2010EP2261358A2 Novel streptococcus antigen
12/15/2010EP2261357A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261356A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261355A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261354A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261353A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261352A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261351A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261350A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261349A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261348A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261347A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261346A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261345A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261344A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261343A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261342A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261341A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261340A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261339A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261338A2 Neisseria meningitidis antigens and compositions
12/15/2010EP2261337A1 DNA sequence and recombinant production of group 4 major allergens from cereals
12/15/2010EP2261336A1 DNA sequence and recombinant production of group 4 major allergens from cereals
12/15/2010EP2261335A1 Compositions and methods for increasing bone mineralisation
12/15/2010EP2261327A2 A group of novel enantioselective microbial nitrile hydratases with broad substrate specificity
12/15/2010EP2261326A1 Novel trichoderma genes
12/15/2010EP2261256A2 Methods of inhibiting metastasis
12/15/2010EP2261251A2 Methods for the synthesis of a modified hemoglobin solution
12/15/2010EP2261250A1 Albumin fusion proteins
12/15/2010EP2261249A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261248A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261247A2 KDR peptides and vaccines comprising the same
12/15/2010EP2261246A2 Binding polypeptides for B-lymphocyte stimulator protein (BLyS)
12/15/2010EP2261245A1 GLP-1 (glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance
12/15/2010EP2261244A2 Human il-18 substitution mutants and their conjugates
12/15/2010EP2261243A2 Hemopexin-like structure as polypeptide-scaffold
12/15/2010EP2261242A1 Aspartate-N-acetyltransferase enzyme, diagnostic method and therapeutic method
12/15/2010EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2010EP2261240A2 Biosensor compositions and methods of use
12/15/2010EP2261239A2 Multiple variants of meningococcal protein NMB1870
12/15/2010EP2261237A2 Daptomycin and related analogs in crystalline form, their preparation and use
12/15/2010EP2261228A1 Promoters for regulation of gene expression in plant roots
12/15/2010EP2261227A1 Promoters for regulation of gene expression in plant roots
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260054A1 Purified immunoglobulin fusion proteins and methods of their purification
12/15/2010EP2259796A2 Materials and methods for improved immunoglycoproteins
12/15/2010EP2259774A1 Methods and compositions for delivering interleukin-1 receptor antagonist
12/15/2010EP1933866B1 Canine influenza virus and related compositions and methods of use
12/15/2010EP1931704B1 Production and purification of il-29
12/15/2010EP1831248B1 Pasteurella multocida vaccine
12/15/2010EP1799838B1 Methods of producing bioactive compositions
12/15/2010EP1778724B1 Antiangiogenic peptides
12/15/2010EP1758998B1 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
12/15/2010EP1725668B1 Genetically modified plants and their applications in phytoremediation.
12/15/2010EP1694709B1 Recombinant anti-cd64-eta' immunotoxins
12/15/2010EP1635855B1 Selective r-cadherin antagonists and methods
12/15/2010EP1558285B1 Method for decreasing depression by inhibiting the activity of n-type calcium channel
12/15/2010EP1525313B1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase
12/15/2010EP1444523B1 Screening for hepatitis c virus entry inhibitors
12/15/2010EP1353942B1 Peptide inhibitors of hiv entry
12/15/2010EP1123977B1 GENES ENCODING PROTEINS REGULATING pH OF VACUOLES
12/15/2010EP1076703B2 Therapeutic uses of il-17 homologous polypeptides
12/15/2010EP1053001B1 Novel mixed amylin activity compounds
12/15/2010EP1001987B1 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
12/15/2010CN1993138B Method of stabilizing proteins
12/15/2010CN1802386B GLP-1 analog fusion proteins
12/15/2010CN1786026B Production technology of fluorescent phycocyanin and crystal and product thereof
12/15/2010CN1786025B Production technology of allophycocyanin and crystal and product thereof
12/15/2010CN1786024B Production technology of phycoerythrin and crystal and product thereof
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 2916